Year in Review 2018 by LACOG Genitourinary Cancer Group: Urological Tumors
Several and important changes in the treatment of urological tumors occurred in 2018. The studies with apalutamide (SPARTAN) and enzalutamide (PROSPER) prior to the development of metastases benefited patients with castration resistant prostate cancer. Prostate radiotherapy to the metastatic prostat...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações Ltda.
2018-10-01
|
| Series: | Brazilian Journal of Oncology |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.5935/1806-6054.20190003 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|